Evidence map›Paper›PMID 26441682›Full record

ArticleFrontiers in physiology2015

Stem cell origin differently affects bone tissue engineering strategies.

Monica Mattioli-Belmonte, Gabriella Teti, Viviana Salvatore, Stefano Focaroli, Monia Orciani, Manuela Dicarlo, Milena Fini, Giovanna Orsini, Roberto Di Primio, Mirella Falconi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Editorial: Stem Cells in Oral Cavity: From Development to Regeneration.Frontiers in cell and developmental biology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Monica Mattioli-BelmonteDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy.
Gabriella TetiDepartment of Biomedical and Neuromotor Sciences, University of Bologna Bologna, Italy.
Viviana SalvatoreDepartment of Biomedical and Neuromotor Sciences, University of Bologna Bologna, Italy.
Stefano FocaroliDepartment of Biomedical and Neuromotor Sciences, University of Bologna Bologna, Italy.
Monia OrcianiDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy.
Manuela DicarloDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy.
Milena FiniLaboratory of Preclinical and Surgical Studies, Rizzoli Orthopaedic Institute Bologna, Italy.
Giovanna OrsiniDepartment of Clinical Sciences and Stomatology, Università Politecnica delle Marche Ancona, Italy.
Roberto Di PrimioDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy.
Mirella FalconiDepartment of Biomedical and Neuromotor Sciences, University of Bologna Bologna, Italy.
Marche Polytechnic University · ITUniversity of Bologna · ITIstituto Ortopedico Rizzoli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone tissue engineering approaches are encouraging for the improvement of conventional bone grafting technique drawbacks. Thanks to their self-renewal and multi-lineage differentiation ability, stem cells are one of the major actors in tissue engineering approaches, and among these adult mesenchymal stem cells (MSCs) hold a great promise for regenerative medicine strategies. Bone marrow MSCs (BM-MSCs) are the first- identified and well-recognized stem cell population used in bone tissue engineering. Nevertheless, several factors hamper BM-MSC clinical application and subsequently, new stem cell sources have been investigated for these purposes. The fruitful selection and combination of tissue engineered scaffold, progenitor cells, and physiologic signaling molecules allowed the surgeon to reconstruct the missing natural tissue. On the basis of these considerations, we analyzed the capability of two different scaffolds, planned for osteochondral tissue regeneration, to modulate differentiation of adult stem cells of dissimilar local sources (i.e., periodontal ligament, maxillary periosteum) as well as adipose-derived stem cells (ASCs), in view of possible craniofacial tissue engineering strategies. We demonstrated that cells are differently committed toward the osteoblastic phenotype and therefore, taking into account their specific features, they could be intriguing cell sources in different stem cell-based bone/periodontal tissue regeneration approaches.

Indexed as

ASCsPDL-SCsPDPCsq-RT-PCRSEMTEMtissue engineering

Identifiers

PMID26441682
PMCPMC4585109
OpenAlexW2097178758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.